E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/1/2008 in the Prospect News PIPE Daily.

New Issue: Medasorb Technologies sells $4.28 million of 10% convertible preferreds

By Angela McDaniels

Tacoma, Wash., July 1 - Medasorb Technologies Corp. raised $4.28 million from a private placement of convertible series B preferred stock, according to an 8-K filing with the Securities and Exchange Commission.

The company sold 42,750 preferreds for $100 each to a group of 10 investors led by NJTC Venture Fund SBIC, LP.

Dividends on the preferreds accrue at 10% per year and are payable quarterly in additional shares of series B preferred stock. After five years, the dividends will be payable in cash.

The conversion rate is one share of common stock for each $0.035 of amount of preferreds.

The preferreds are putable for par plus accrued dividends at the option of a majority of the holders beginning five years after issuance, provided that the current stock price is less than the conversion price.

In addition to the preferreds, the investors received a security to purchase additional preferreds within 15 months at $100 each.

The company said that in connection with the private placement, $175,000 of debt was converted into 1,750 additional preferreds, and NJTC Venture Fund is entitled to elect two directors to the company's board.

Medasorb is a development-stage medical device company based in Monmouth, N.J., that is developing an adsorbent platform technology for removal of toxins from blood and physiologic fluids.

Issuer:Medasorb Technologies Corp.
Issue:Convertible series B preferred stock
Amount:$4,275,000
Shares:42,750
Dividends:10%, payable quarterly
Price:$100
Warrants:No
Investors:NJTC Venture Fund SBIC, LP (lead)
Settlement date:June 25
Stock symbol:OTCBB: MSBT
Stock price:$0.13 on July 1

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.